Literature DB >> 24314670

Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.

Dinesh Addla1, Anvesh Jallapally1, Divya Gurram1, Perumal Yogeeswari2, Dharmarajan Sriram2, Srinivas Kantevari3.   

Abstract

Molecular hybridization is an emerging structural modification tool to design molecules with better pharmacophoric properties. A series of novel 2-(trifluoromethyl)phenothiazine-1,2,3-triazoles 5a-v designed by hybridizing two antitubercular drugs trifluoperazine and I-A09 in a single molecular architecture, were synthesized in very good yields using click chemistry. Among the all '22' compounds screened for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv (Mtb), three analogs 5c, 5l and 5o were found to be most potent (MIC: 6.25μg/mL) antitubercular agents with good selectivity index.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimycobacterial activity; Molecular hybridization; Mycobacterium tuberculosis; Phenothiazine; Triazoles

Mesh:

Substances:

Year:  2013        PMID: 24314670     DOI: 10.1016/j.bmcl.2013.11.031

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Development of Phenothiazine Hybrids with Potential Medicinal Interest: A Review.

Authors:  Marina C Posso; Fernanda C Domingues; Susana Ferreira; Samuel Silvestre
Journal:  Molecules       Date:  2022-01-03       Impact factor: 4.411

2.  Design and synthesis of magnetic Fe3O4@NFC-ImSalophCu nanocatalyst based on cellulose nanofibers as a new and highly efficient, reusable, stable and green catalyst for the synthesis of 1,2,3-triazoles.

Authors:  Pouya Ghamari Kargar; Ghodsieh Bagherzade; Hossein Eshghi
Journal:  RSC Adv       Date:  2020-09-04       Impact factor: 3.361

3.  Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.

Authors:  Rajappan Revathi; Ramachandran Venkatesha Perumal; Karkala Sreedhara Ranganath Pai; Govindakarnavar Arunkumar; Dharmarajan Sriram; Suvarna Ganesh Kini
Journal:  Drug Des Devel Ther       Date:  2015-07-21       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.